Stock listing

26CA Stock Price, News, Filings & Events — Immunitybio, Inc.

Selected listing: 26CA · GETTEX · EUR · DE

26CA:GETTEX represents Immunitybio, Inc., a biotechnology company dedicated to developing innovative immunotherapy solutions for various diseases. With a market capitalization of approximately $8.04 billion, Immunitybio is recognized for its commitment to advancing healthcare through cutting-edge research. The company continues to make strides in the biotechnology sector, with ongoing developments and updates that reflect its focus on addressing critical health challenges. Investors can stay informed about the latest news, filings, and events related to Immunitybio's progress and market context.

26CA:GETTEXEURDEUpdated July 31, 2026
Immunitybio, Inc. logo
Ticker
26CA:GETTEX
Asset type
Stock
Market cap
$7.51B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
GETTEX
Currency
EUR

Immunitybio, Inc. 26CA:GETTEX stock context

26CA:GETTEX represents Immunitybio, Inc., a biotechnology company dedicated to developing innovative immunotherapy solutions for various diseases. With a market capitalization of approximately $8.04 billion, Immunitybio is recognized for its commitment to advancing healthcare through cutting-edge research. The company continues to make strides in the biotechnology sector, with ongoing developments and updates that reflect its focus on addressing critical health challenges. Investors can stay informed about the latest news, filings, and events related to Immunitybio's progress and market context.

Research Immunitybio, Inc.

Alternate listings